Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aged 18 Years and Older”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Testing effectiveness (Phase 2)UnknownNCT05239832
What this trial is testing

Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 34
Large-scale testing (Phase 3)Looking for participantsNCT07729462
What this trial is testing

Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine

Who this might be right for
Preventive Treatment of Migraine
Pfizer 400
Large-scale testing (Phase 3)Study completedNCT01884519
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 120
Testing effectiveness (Phase 2)UnknownNCT00652184
What this trial is testing

Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)

Who this might be right for
Herpes ZosterPostherpetic Neuralgia
aRigen Pharmaceuticals, Inc. 300
Early research (Phase 1)Study completedNCT06507553
What this trial is testing

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

Who this might be right for
InfluenzaHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 400
Early research (Phase 1)Study completedNCT04530656
What this trial is testing

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 168
Testing effectiveness (Phase 2)Study completedNCT06431607
What this trial is testing

Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 845
Testing effectiveness (Phase 2)UnknownNCT05273528
What this trial is testing

The Immunogenicity and Safety of V-01-351/V-01D Bivalence Vaccine

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 20
Testing effectiveness (Phase 2)Study completedNCT06680128
What this trial is testing

Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

Who this might be right for
Japanese Encephalitis Virus Disease
SK Bioscience Co., Ltd. 161
Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Testing effectiveness (Phase 2)UnknownNCT05238649
What this trial is testing

Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 150
Early research (Phase 1)Study completedNCT04495933
What this trial is testing

A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults

Who this might be right for
SARS-CoV2Covid19
The University of Queensland 216
Large-scale testing (Phase 3)Study completedNCT06389487
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,459
Large-scale testing (Phase 3)Study completedNCT01344447
What this trial is testing

Gadobutrol Enhanced MRA of the Supra-aortic Vessels

Who this might be right for
Carotid Stenosis
Bayer 479
Large-scale testing (Phase 3)Study completedNCT04754594
What this trial is testing

To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCOVID-19Maternal Immunization
BioNTech SE 726
Testing effectiveness (Phase 2)Study completedNCT02508207
What this trial is testing

Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 34
Early research (Phase 1)Study completedNCT01855945
What this trial is testing

Safety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.

Who this might be right for
Prophylaxis of A/H3N2v Influenza
Novartis Vaccines 627
Testing effectiveness (Phase 2)Study completedNCT04840992
What this trial is testing

Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation

Who this might be right for
COVID-19
CanSino Biologics Inc. 840
Not applicableStudy completedNCT00179335
What this trial is testing

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Who this might be right for
HIV Infections
Albert Einstein College of Medicine 45
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation